Featured Article
True or false: Among patients with antibody-mediated autoimmune encephalitis, plasma neurofilament light has been identified as a potential biomarker.
Using plasma and cerebrospinal fluid samples, researchers investigated a potential biomarker for antibody-mediated autoimmune encephalitis. The findings were presented at the American Neurological Association’s 145th Annual Meeting.
The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
Each year, thousands of Americans are diagnosed with amyotrophic lateral sclerosis. Do you know which patient populations are more likely to be diagnosed with the progressive neurodegenerative disease? Find out by answering this pop quiz question.
To investigate the etiology of acute flaccid myelitis, researchers examined cerebrospinal fluid samples from 29 children with AFM and 71 unmatched children with other neurologic diseases.
Thousands of Americans have Lou Gehrig disease. Do you know when the progressive neurodegenerative disease was discovered? Answer this question to find out.